Transanal hemorrhoidal dearterialization (THD): a safe procedure for the anticoagulated patient?

Techniques in Coloproctology

Volumn 20, Issue 7, 2016, Pages 461-466

  Atallah, S ^a   Maharaja, G K ^a   Martin Perez, B ^a   Burke, J P ^a   Albert, M R ^a   Larach, S W ^a  

^a FLORIDA HOSPITAL   (United States)

Author keywords

Anticoagulation; Hemorrhoids; Postoperative hemorrhage; THD; Transanal hemorrhoidal dearterialization

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMORRHOID; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MORBIDITY; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL TECHNIQUE; TRANSANAL HEMORRHOIDAL DEARTERIALIZATION; TREATMENT OUTCOME; ADVERSE EFFECTS; HEMORRHOIDECTOMY; HEMORRHOIDS; MIDDLE AGED; OPERATION DURATION; OPERATIVE BLOOD LOSS; PROCEDURES; TRANSANAL ENDOSCOPIC SURGERY;

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; FEMALE; HEMORRHOIDECTOMY; HEMORRHOIDS; HUMANS; MALE; MIDDLE AGED; OPERATIVE TIME; POSTOPERATIVE HEMORRHAGE; RECURRENCE; RETROSPECTIVE STUDIES; TRANSANAL ENDOSCOPIC SURGERY;

EID: 84966702124     PISSN: 11236337     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s10151-016-1481-z     Document Type: Article

References (43)

1. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH (2006) Aspirin use among US adults: behavioral risk factor surveillance system. Am J Prev Med 30:74–77
2. Anita Soni (2005) Aspirin use among the adult U.S. noninstitutionalized population, with and without indicators of heart disease. Statistical Brief #179. http://meps.ahrq.gov/mepsweb/data_files/publications/st179/stat179.pdf
3. Topol EJ, Schork NJ (2011) Catapulting clopidogrel pharmacogenomics forward. Nat Med 17:40–41
4. Pirmohamed M (2006) Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol 62:509–511
5. Di Nisio M, Middeldorp S, Büller H (2005) Direct thrombin inhibitors. N Engl J Med 353:1028–1040
6. Siegal DM, Curnutte JT, Connolly SJ et al (2015) Andexanet Alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 17:2413–2424
7. Fox A, Tietze PH, Ramakrishnan K (2014) Anorectal conditions: hemorrhoids. FP Essent 419:11–19
8. Cataldo P, Ellis CN, Gregorcyk S et al (2005) Standards Practice Task Force, The American Society of Colon and Rectal Surgeons, USA. Practice parameters for the management of hemorrhoids (revised). Dis Colon Rectum 48:189–194
9. Wang Q, Cai C, Dong W, Du J (2014) Severe intra-abdominal bleeding leading to hemorrhagic shock, rectal perforation and bilateral hydrothorax after stapling procedure for prolapsed hemorrhoids. Tech Coloproctol 18:771–772
10. Festen S, van Hoogstraten MJ, van Geloven AA, Gerhards MF (2009) Treatment of grade III and IV haemorrhoidal disease with PPH or THD. A randomized trial on postoperative complications and short-term results. Int J Colorectal Dis 24:1401–1405
11. Odelowo O, Mekasha G, Johnson MA (2002) Massive life-threatening lower gastrointestinal hemorrhage following hemorrhoidal rubber band ligation. J Natl Med Assoc 94:1089–1092
12. Patel S, Shahzad G, Rizvon K, Subramani K, Viswanathan P, Mustacchia P (2014) Rectal ulcers and massive bleeding after hemorrhoidal band ligation while on aspirin. World J Clin Cases 16:86–89
13. Bat L, Melzer E, Koler M, Dreznick Z, Shemesh E (1993) Complications of rubber band ligation of symptomatic internal hemorrhoids. Dis Colon Rectum 36:287–290
14. Chen HH, Wang JY, Changchien CR et al (2002) Risk factors associated with posthemorrhoidectomy secondary hemorrhage: a single-institution prospective study of 4880 consecutive closed hemorrhoidectomies. Dis Colon Rectum 45:1096–1099
15. Rosen L, Sipe P, Stasik JJ, Riether RD, Trimpi HD (1993) Outcome of delayed hemorrhage following surgical hemorrhoidectomy. Dis Colon Rectum 36:743–746
16. De Nardi P, Capretti G, Corsaro A, Staudacher C (2014) A prospective, randomized trial comparing the short- and long-term results of doppler-guided transanal hemorrhoid dearterialization with mucopexy versus excision hemorrhoidectomy for grade III hemorrhoids. Dis Colon Rectum 57:348–353
17. Ratto C, Parello A, Veronese E et al (2015) Doppler-guided transanal haemorrhoidal dearterialization for haemorrhoids: results from a multicentre trial. Colorectal Dis 17:O10–O19
18. Denoya P, Tam J, Bergamaschi R (2014) Hemorrhoidal dearterialization with mucopexy versus hemorrhoidectomy: 3-year follow-up assessment of a randomized controlled trial. Tech Coloproctol 18:1081–1085
19. Cavazzoni E, Bugiantella W, Graziosi L et al (2013) Emergency transanal haemorrhoidal Doppler guided dearterialization for acute and persistent haemorrhoidal bleeding. Colorectal Dis 15:e89–e92
20. Goligher JC, Leacock AG, Brossy JJ (1955) The surgical anatomy of the anal canal. Br J Surg 43:51–61
21. Kearon C, Hirsh J (1997) Management of anticoagulation before and after elective surgery. N Engl J Med 22:1506–1511
22. Douketis JD, Crowther MA, Cherian SS, Kearon CB (1999) Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 1:1240–1246
23. Sherwood MW, Nessel CC, Hellkamp AS et al (2015) Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF Trial. J Am Coll Cardiol 1:2271–2281
24. Abraham NS, Singh S, Alexander GC et al (2015) Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 24:h1857
25. Genewein U, Haeberli A, Straub PW, Beer JH (1996) Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haemotol 1:479–485
26. Harenberg J, Haas R, Zimmermann R (1983) Plasma hypercoagulability after termination of oral anticoagulants. Thromb Res 15:627–633
27. Sise HS, Moschos CB, Gauthier J, Becker R (1961) The risk of interrupting long-term anticoagulant treatment a rebound hypercoagulable state following hemorrhage. Circulation 1:1137–1142
28. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 8:1009–1019
29. Pfisterer M, Brunner-La Rocca HP, Buser PT et al (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 19:2584–2591
30. Cannegieter SC, Rosendaal FR, Wintzen AR, Van der Meer FJ, Vandenbroucke JP, Briet E (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 6:11–17
31. Hammerstingl C, Tripp C, Schmidt H, von der Recke G, Omran H (2007) Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis 16:285–292
32. Smith SC, Allen J, Blair SN et al (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart. J Am Coll Cardiol 16:2130–2139
33. Larsen TB, Lip GY, Gorst-Rasmussen A (2016) Anticoagulant therapy after venous thromboembolism and 10-year mortality. Int J Cardiol 18:72–78
34. Douketis JD, Healey JS, Brueckmann M et al (2015) Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost 113:625–632
35. Kozek-Langenecker SA (2014) Perioperative management issues of direct oral anticoagulants. Semin Hematol 51:112–120
36. Dunn AS, Spyropoulos AC, Turpie AG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 1:2211–2218
37. Douketis JD, Johnson JA, Turpie AG (2004) Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern 28:1319–1326
38. Hammerstingl C, Schmitz A, Fimmers R, Omran H (2009) Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry. Cardiovasc Ther 1:230–238
39. Spyropoulos AC, Jenkins P, Bornikova L (2004) A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation. Pharmacotherapy 24:649–658
40. Seshadri N, Goldhaber SZ, Elkayam U et al (2005) The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J 1:27–34
41. Serebruany VL, Steinhubl SR, Berger PB et al (2005) Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol 15:1218–1222
42. Nelson RS, Thorson AG (2009) Risk of bleeding following hemorrhoidal banding in patients on antithrombotic therapy. Gastroenterol Clin Biol 33:463–465
43. Iyer VS, Shrier I, Gordon PH (2004) Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum 1:1364–1370